Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Parent Perspectives on Nirsevimab for Their Newborn
2024
· Yale School of Medicine,
· Yale University
This article explores how parents feel about using nirsevimab for their newborns. Nirsevimab is a medicine that helps protect babies from RSV, a common virus …
Ask aRCie
Should You Get an RSV Vaccine?
2025
· Yale University
This news article describes the importance of getting an RSV vaccine, especially for older adults and babies. RSV is a virus that can cause serious …
Improving Palivizumab Administration to High-Risk Infants with Heart Disease via a Communication-Based Quality Improvement Initiative
2025
· Yale University,
· Yale New Haven Health System
This article describes a project to improve the administration of palivizumab, a medication for high-risk infants with heart disease. A team at Yale University worked …
Challenges in Maximizing Impacts of Preventive Strategies Against Respiratory Syncytial Virus (RSV) Disease in Young Children
2022
· Yale University
This article discusses the challenges and advancements in preventive strategies against Respiratory Syncytial Virus (RSV) disease in young children. RSV is a common cause of …
Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease in Infants: A Canadian Immunisation Research Network (CIRN) Study
2023
· York University,
· Yale University,
· Dalhousie University
This study looks at the cost-effectiveness of two strategies to prevent RSV disease in infants in Canada. It describes using nirsevimab, a long-acting antibody, for …
Cost-Effectiveness Analysis of Nirsevimab and Maternal Rsvpref Vaccine Strategies for Prevention of Respiratory Syncytial Virus Disease Among Infants in Canada: A Simulation Study
2023
· Yale University,
· York University,
· Dalhousie University
This study in Canada assessed cost-effectiveness of nirsevimab and RSVpreF for preventing RSV in infants. Modeling different interventions showed immunizing the birth cohort with nirsevimab …
Game Over for RSV?
2023
· Yale University
This letter comments on a study by D. Wilkins and colleagues and concludes that passive immunization with nirsevimab protects infants from severe respiratory syncytial virus …
Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists
2024
· Yale School of Medicine,
· Stanford University,
· Seattle Children's Hospital,
· The University of Chicago Medicine,
· Nationwide Children's Hospital,
· Yale University
This article discusses the implementation of newly developed nirsevimab into clinical practice. Approved in July 2023, it is costly and has supply issues. Hospitals struggle …
Real-World Effectiveness of Nirsevimab Against Respiratory Syncytial Virus: A Test-Negative Case-Control Study
2024
· Yale School of Medicine,
· Yale University
This article describes a study that evaluated the effectiveness of nirsevimab in preventing RSV infections in infants. It included 3,090 infants and found that nirsevimab …
Factors Associated With Nirsevimab Uptake in Healthy Newborns
2024
· Yale School of Medicine,
· Yale University
This research brief discusses a study that looks at factors affecting the use of nirsevimab, a new antibody for RSV, in newborns. It explains how …